Floor J. Backes, MD
Robert L. Coleman, MD, FACOG, FACS
Keeping Pace in Women’s Cancers: Ovarian Cancer—From IO to PARP
Federico Cappuzzo
Professor Solange Peters
Professor Yi-Long Wu
The Latest Clinical Considerations for Non-Small Cell Lung Cancer: A Global Approach
The Latest Clinical Considerations for Non-Small Cell Lung Cancer: A Global A...
Peter Schmid, FRCP, MD, PhD
Javier Cortes, MD, PhD
Keeping Pace in Women’s Cancers: Updates in Triple-Negative Breast Cancer
Marianne J. Davies, DNP, ACNP, AOCNP
Julie R. Brahmer, MD, MSc
Addressing Barriers in Managing IRAEs Associated with Immune Checkpoint Inhibitor Therapy
Addressing Barriers in Managing IRAEs Associated with Immune Checkpoint Inhib...
Scott Kopetz, MD, PhD
Prof Eric Van Cutsem, MD, PhD
Latest Clinical Advances in the Treatment of BRAF V600E-Mutated Metastatic Colorectal Cancer
Latest Clinical Advances in the Treatment of BRAF V600E-Mutated Metastatic Co...
Richard T. Penson, MD, MRCP
Linda R. Duska, MD, MPH
Keeping Pace in Women’s Cancer: Focus on Endometrial Carcinoma
John Healey, MD
William D. Tap, MD
A Multidisciplinary Approach to Treatment of Tenosynovial Giant Cell Tumor (TGCT)
A Multidisciplinary Approach to Treatment of Tenosynovial Giant Cell Tumor (T...
Mark A. Socinski, MD
Gilberto de Lima Lopes Junior, MD, MBA, FAMS
Keeping Pace: The Use of Immunotherapy in Mutation-Positive Non-Small Cell Lung Cancer
Keeping Pace: The Use of Immunotherapy in Mutation-Positive Non-Small Cell Lu...
William J. Gradishar MD, FASCO, FACP
Perspectives for Clinical Practice: The Latest Advances for HER2-positive Metastatic Breast Cancer
Perspectives for Clinical Practice: The Latest Advances for HER2-positive Met...
Edward B. Garon, MD, MS
Keeping Pace: The Role of Immunotherapy After Disease Progression
Ana Ferreira Castro, MD
Gilberto de Castro Junior, MD, PhD
Zujun Li, MD
Ricard Mesia, MD, PhD
Clinical Considerations in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
Clinical Considerations in Recurrent/Metastatic Squamous Cell Carcinoma of th...
Actualización sobre inmunoterapia: tratamiento de carcinoma recurrente o metastásico de células escamosas de la cabeza y el cuello
Actualización sobre inmunoterapia: tratamiento de carcinoma recurrente o meta...
Giuseppe Curigliano, MD, PhD
Real-World Evidence and Clinical Decision-Making for HR-positive/HER2-negative Metastatic Breast Cancer
Real-World Evidence and Clinical Decision-Making for HR-positive/HER2-negativ...
D. Ross Camidge, MD, PhD
Luis Paz-Ares, MD, PhD
Acquired Resistance to Targeted Therapy of NSCLC: A Global Perspective
Everett E. Vokes, MD
The Changing Landscape of NSCLC: MET Inhibitors
Shira Johnson, MD
Robert Vonderheide, MD
CAR-T Cell Therapy: A Breakthrough Treatment for Fighting Cancer
Loading...
Stay current with the best on medical education
Learn More
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We’re glad to see you’re enjoying Global Oncology Academy…but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.
